- Home
- IMMP vs EVGO Comparison
IMMP vs EVGO Comparison
Compare IMMP & EVGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- EVGO
- Stock Information
- Founded
- IMMP 1987
- EVGO 2010
- Country
- IMMP Australia
- EVGO United States
- Employees
- IMMP N/A
- EVGO N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- EVGO Other Specialty Stores
- Sector
- IMMP Health Care
- EVGO Consumer Discretionary
- Exchange
- IMMP Nasdaq
- EVGO Nasdaq
- Market Cap
- IMMP 251.8M
- EVGO 532.0M
- IPO Year
- IMMP N/A
- EVGO N/A
- Fundamental
- Price
- IMMP $1.69
- EVGO $4.67
- Analyst Decision
- IMMP Buy
- EVGO Strong Buy
- Analyst Count
- IMMP 1
- EVGO 10
- Target Price
- IMMP $7.00
- EVGO $6.10
- AVG Volume (30 Days)
- IMMP 88.5K
- EVGO 3.3M
- Earning Date
- IMMP 10-21-2025
- EVGO 11-11-2025
- Dividend Yield
- IMMP N/A
- EVGO N/A
- EPS Growth
- IMMP N/A
- EVGO N/A
- EPS
- IMMP N/A
- EVGO N/A
- Revenue
- IMMP $3,306,742.00
- EVGO $308,365,000.00
- Revenue This Year
- IMMP N/A
- EVGO $45.45
- Revenue Next Year
- IMMP $725.37
- EVGO $26.93
- P/E Ratio
- IMMP N/A
- EVGO N/A
- Revenue Growth
- IMMP 31.28
- EVGO 49.06
- 52 Week Low
- IMMP $1.32
- EVGO $2.20
- 52 Week High
- IMMP $2.71
- EVGO $9.07
- Technical
- Relative Strength Index (RSI)
- IMMP 50.49
- EVGO 71.29
- Support Level
- IMMP $1.60
- EVGO $3.80
- Resistance Level
- IMMP $1.76
- EVGO $3.98
- Average True Range (ATR)
- IMMP 0.06
- EVGO 0.21
- MACD
- IMMP 0.01
- EVGO 0.06
- Stochastic Oscillator
- IMMP 55.88
- EVGO 88.46
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About EVGO EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.